Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations - Shekhtman, Louis; Cotler, Scott J.; Degasperi, Elisabetta; Anolli, Maria Paola; Uceda Renteria, Sara Colonia; Sambarino, Dana; Borghi, Marta; Perbellini, Riccardo; Facchetti, Floriana; Ceriotti, Ferruccio; Lampertico, Pietro; Dahari, Harel (JHEP reports, 2024)
Keywords: ALT; Bulevirtide; Gastroenterology and Hepatology; HBsAg; HDV RNA; mathematical modeling; LLoQ; BF; HBsAg; ALT; FPR; HDV RNA; TND; Bulevirtide; BLV; CSPH; mathematical modeling; HDV; HBV; CHD; hepatitis B surface antigen; chronic hepatitis D; hepatitis B virus; alanine aminotransferase; flat-partial response; body fluid; clinically significant portal hypertension; target not detected; hepatitis D virus; lower limit of quantification